• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

GW Pharmaceuticals PLC

+ Add to Watchlist

GW2:GR

4.419 EUR 0.331 6.97%

As of 15:20:03 ET on 12/23/2014.

Snapshot for GW Pharmaceuticals PLC (GW2)

Open: 4.757 Day's Range: 4.419 - 4.780 Volume: 340
Previous Close: 4.750 52wk Range: 2.030 - 6.850 1-Yr Rtn: +112.15%

Stock Chart for GW2

No chart data available.
  • GW2:GR 4.730
  • 1D
  • 1M
  • 1Y
4.750
Interactive GW2 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for GW2

Current P/E Ratio (ttm) -
Estimated P/E(09/2015) -
Relative P/E vs. DAX -
Earnings Per Share (GBP) (ttm) -
Est. EPS (GBP) (09/2015) -0.1340
Est. PEG Ratio -
Market Cap (M EUR) 1,045.91
Shares Outstanding (M) 236.69
30 Day Average Volume 845
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/05/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for GW2

  • Revenue
  • Net Income (M/GBP)
  • Profit Margin (%)

Company Profile & Key Executives for GW2

GW Pharmaceuticals plc researches and develops cannabinoid prescription medicines for the treatment of cancer pain, Multiple Sclerosis, and neuropathic pain.

Geoffrey William GuyChairman/FounderJustin David GoverChief Executive Officer
Adam David GeorgeCFO/SecretaryChristopher John Tovey "Chris"Chief Operating Officer
More Company Profile & Key Executives for GW2

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil